Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial

Intanza(®)/IDflu(®) (Sanofi Pasteur, Lyon, France) is an intradermal inactivated trivalent influenza vaccine developed as an alternative to intramuscular influenza vaccine. The objective of this study was to confirm the immunogenicity and safety of Intanza/IDflu in South Korean adults. In a phase IV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoon Han, Sang, Hee Woo, Jun, Weber, Francoise, Joo Kim, Woo, Ran Peck, Kyong, Il Kim, Sang, Hwa Choi, Young, Myung Kim, June
Format: Artigo
Sprache:Inglês
Veröffentlicht: Landes Bioscience 2013
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906364/
https://ncbi.nlm.nih.gov/pubmed/23778938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.25295
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge